The latest insights, interviews and industry commentary from across the Advanced Therapies Europe community. Covering European market developments, CGT innovation and the conversations shaping the future of advanced therapies.
-
)
China is accelerating early-stage development through faster clinical approvals and more flexible trial infrastructure t ... -
)
Why Patient Access Must Shape ATMP Development Looking back at your career in advanced therapies and ATMP development, w ... -
)
Why early engagement with regulators and payers is becoming critical to accelerating access, reimbursement, and long-ter ... -
)
ArticlePhacilitate Newsletter: April
April marked a subtle but meaningful shift in advanced therapies. Across deals, funding, and industry conversations, the ... -
)
Aleck Jones, CEO and Co-Founder of Kindling Bio and winner of the Advanced Therapies Europe 2025 Innovation Exchange (sp ... -
)
ArticleFrom Pessimism to Mega Deals: The New Biotech Playbook for Funding, Focus, and Commercial Reality
Despite the gloom, the data say otherwise: record UK raises and a string of $100M+ “mega deals” across AAV, mRNA, and ce ... -
)
ArticleFrom Stick to Sphere: How Okon Pivoted, Fundraised, and Survived in Women’s-Health Therapeutics
Former Okon Therapeutics CEO Keren Leshem lays out how a contraceptive “ball” IUD became a uterine drug-delivery platfor ... -
)
Late-stage AAV success is less about bigger bioreactors and more about decisions that lock in supply, comparability, and ... -
)
ArticleFrom Central Plants to Smart Hubs: How AI and Inline Analytics Will Decentralize CGT Manufacturing
The panel agrees the future is decentralized, hybrid, and data driven. Inline analytics, digital batch records, and AI w ... -
)
ArticleRethinking Access & Advancement: A Practical Playbook for Women (and Allies) in Advanced Therapies
The room was full, the stats were sobering, and the advice was refreshingly actionable. Leaders from biotech, tech, and ... -
)
This workshop laid out how biology, platforms, and policy can move genomic medicines from promising pilots to reliable p ... -
)
The UK punches above its weight in advanced therapies: a dense concentration of developers, a single national health sys ... -
)
Cell and gene therapies live or die on logistics. Time, temperature, and traceability must survive every handoff across ... -
)
The Nordic ecosystem leads in discovery and process innovation, supported by a public that embraces medical advances. Ye ... -
)
InterviewBusiness and Biotech: Mayra Battilani on Strategy, Access and the Future of Advanced Therapies
Mayra Battilani Becegato, former EMEA Commercial Strategy Director for Gene Therapy – Rare Diseases at Johnson & Johnson ... -
)
Barcelona is a thriving strategic hub for advanced therapies. At Advanced Therapies Europe 2025, the city becomes more t ... -
)
Get an exclusive first look at what’s in store for Advanced Therapies Europe 2025. This live webinar will explore the ke ... -
)
InterviewFrom Vision to Impact: How Marion Hitchcock Is Powering Europe’s Gene & Cell Therapy Startups
Marion Hitchcock, Managing Director of the Gene & Cell Therapies Incubator Berlin and R&D Strategy & Portfolio Manager a ...